Fungal infections: diagnostic problems and choice of therapy
- PMID: 27175237
- PMCID: PMC4851195
- DOI: 10.1038/leusup.2012.14
Fungal infections: diagnostic problems and choice of therapy
Abstract
Fungi are typically opportunistic pathogens. Formerly, limitations in diagnostic techniques explain why invasive fungal infections are usually detected in a late stage of their development. Therefore, traditional guidelines dictate antifungal treatment for all patients with persisting fever. This is not longer justifiable in view of the potential adverse events and the economical burden associated with the use of the new antifungal drugs in an era with improved diagnostic tools. Amphotericin B has been the drug of choice for invasive fungal infections for more than 30 years. Owing to nephrotoxicity, its use in neutropenic patients has been largely abandoned in favor of a lipid formulation of amphotericin B, of which only liposomal amphotericin B has been scientifically tested in the first-line treatment of aspergillosis. Azoles constitute an acceptable alternative to intravenous amphotericin B for many invasive fungal infections.
Keywords: Aspergillus; Candida; antifungal therapy; fungal infections.
References
-
- Pagano L, Caira M, Nosari A, Van Lint MT, Candoni A, Offidani M et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study—Sorveglianza Epidemiologica Infezioni Fungine nelle Empatie Maligne. Clin Infect Dis 2007; 45: 1161–1170. - PubMed
-
- Blijlevens N, Schwenkglenks M, Bacon P, D'Addio A, Einsele H, Maertens J et al. Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol 2008; 26: 1519–1525. - PubMed
-
- Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002; 186: 1297–1306. - PubMed
-
- Donnelly JP. Polymerase chain reaction for diagnosing invasive aspergillosis:getting closer but still a ways to go. Clin Infect Dis 2006; 42: 487–489. - PubMed
-
- De Pauw BE, Donnelly JP. Prophylaxis and aspergillosis—has the principle been proven? N Engl J Med 2007; 356: 409–411. - PubMed
LinkOut - more resources
Full Text Sources
